Aegis Life’s Investigational DNA Vaccine
John Lewis, Ph.D., CEO of Aegis Life, Inc., a spinout of Entos Pharmaceuticals, discusses the company's goal of developing a novel DNA vaccine using its...
5264 articles
John Lewis, Ph.D., CEO of Aegis Life, Inc., a spinout of Entos Pharmaceuticals, discusses the company's goal of developing a novel DNA vaccine using its...
Caron Jacobson, MD, Clinical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute discusses the blood cancers lymphoma and leuke...
Pam Nisevich Bede, a registered dietitian from Abbott, a global healthcare company and leader in nutrition science, discusses how to get “nutrition st...
Glen de Vries, co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world, shares insights from his new book coming ...
Bryan Witherbee, CEO of Adarza Biosystems discusses ZIVA™, a label-free protein detection platform that can accurately test 100s of protein from a sin...
Kendra Grubb, surgical director of the Emory Structural Heart and Valve Center in Atlanta discusses data from a national survey released by patient advo...
John Martin, CMO of Butterfly Network discusses Butterfly iQ, the world's first handheld, single-probe, whole-body ultrasound system that is making ultr...
Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the three cell therapy programs they currently have in...
Vivian Hernandez-Trujillo, a pediatric allergist, discusses potential challenges children with life-threatening food allergies may face as they return t...
Kathleen Hawker, M.D., Group Medical Director, Neuroscience at Genentech discusses the recent FDA approval of Enspryng™ (satralizumab-mwge) and the fi...